hidradenitis suppurativa

In upcoming skin disease clash, doctors see Novartis' Cosentyx as an underdog
In upcoming skin disease clash, doctors see Novartis' Cosentyx as an underdog
Fierce Pharma
Novartis
Cosentyx
AbbVie
Humira
hidradenitis suppurativa
UCB Pharma
Flag link:
Spotlight – following Humira in hidradenitis suppurativa
Spotlight – following Humira in hidradenitis suppurativa
EP Vantage
AbbVie
Humira
hidradenitis suppurativa
UCB Pharma
Bimzelx
MoonLake Immunotherapeutics
Flag link:
AAD 2023 – UCB and Acelyrin take aim at hidradenitis suppurativa
AAD 2023 – UCB and Acelyrin take aim at hidradenitis suppurativa
EP Vantage
AAD
hidradenitis suppurativa
AbbVie
Humira
UCB Pharma
Bimzelx
Acelyrin
izokibep
Flag link:
Incyte reports new data from hidradenitis suppurativa therapy trial
Incyte reports new data from hidradenitis suppurativa therapy trial
Clinical Trials Arena
Incyte
clinical trials
hidradenitis suppurativa
povorcitinib
Flag link:
First Protein Degrader Tested Outside Oncology Yields Promising Results
First Protein Degrader Tested Outside Oncology Yields Promising Results
BioSpace
Kymera Therapeutics
Sanofi
protein degradation
hidradenitis suppurativa
atopic dermatitis
KT-474
Flag link:
Novartis touts Cosentyx win in debilitating skin condition. Can it challenge AbbVie's Humira?
Novartis touts Cosentyx win in debilitating skin condition. Can it challenge AbbVie's Humira?
Fierce Pharma
Novartis
FDA
Cosentyx
AbbVie
Humira
hidradenitis suppurativa
Flag link:
AnaptysBio's HARP plays dud note, prompting rethink of imsidolimab strategy
AnaptysBio's HARP plays dud note, prompting rethink of imsidolimab strategy
Fierce Biotech
AnaptysBio
imsidolimab
hidradenitis suppurativa
Flag link:
Kymera’s pain could be Priovant’s gain
Kymera’s pain could be Priovant’s gain
EP Vantage
Pfizer
hidradenitis suppurativa
Kymera
Priovant
AbbVie
Flag link:
Chemocentryx takes a leap of faith with avacopan
Chemocentryx takes a leap of faith with avacopan
EP Vantage
ChemoCentryx
avacopan
clinical trials
hidradenitis suppurativa
Flag link:
AbbVie nabs FDA's orphan drug tag for Humira in HS
AbbVie nabs FDA's orphan drug tag for Humira in HS
Fierce Pharma
AbbVie
FDA
Humira
orphan drugs
hidradenitis suppurativa
Flag link:
AbbVie's Humira Positive in Phase III Skin Disease Study
AbbVie's Humira Positive in Phase III Skin Disease Study
Yahoo/Zacks.com
AbbVie
Humira
hidradenitis suppurativa
Flag link:
Abbott begins patient enrollment in two Phase 3 studies of HUMIRA
Abbott begins patient enrollment in two Phase 3 studies of HUMIRA
Yahoo/Fly on the Wall
Abbott Laboratories
Humira
hidradenitis suppurativa
Flag link: